BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 31786254)

  • 1. Eosinophilic Asthma.
    Nelson RK; Bush A; Stokes J; Nair P; Akuthota P
    J Allergy Clin Immunol Pract; 2020 Feb; 8(2):465-473. PubMed ID: 31786254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of lower airway inflammation in patients with NSAID-exacerbated respiratory disease.
    Jakiela B; Soja J; Sladek K; Przybyszowski M; Plutecka H; Gielicz A; Rebane A; Bochenek G
    J Allergy Clin Immunol; 2021 Apr; 147(4):1269-1280. PubMed ID: 32810516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of NSAID-Exacerbated Respiratory Disease: has the time come for subphenotyping?
    Kowalski ML
    Curr Opin Pulm Med; 2019 Jan; 25(1):64-70. PubMed ID: 30489335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps.
    Weinstein SF; Katial RK; Bardin P; Korn S; McDonald M; Garin M; Bateman ED; Hoyte FCL; Germinaro M
    J Allergy Clin Immunol Pract; 2019 Feb; 7(2):589-596.e3. PubMed ID: 30193936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilic Endotype of Asthma.
    Aleman F; Lim HF; Nair P
    Immunol Allergy Clin North Am; 2016 Aug; 36(3):559-68. PubMed ID: 27401626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin or other nonsteroidal inflammatory agent exacerbated asthma.
    Ledford DK; Wenzel SE; Lockey RF
    J Allergy Clin Immunol Pract; 2014; 2(6):653-7. PubMed ID: 25439353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cromolyn sodium suppresses eosinophilic inflammation in patients with aspirin-intolerant asthma.
    Amayasu H; Nakabayashi M; Akahori K; Ishizaki Y; Shoji T; Nakagawa H; Hasegawa H; Yoshida S
    Ann Allergy Asthma Immunol; 2001 Aug; 87(2):146-50. PubMed ID: 11527248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Biomarkers for NSAID-Exacerbated Respiratory Disease.
    Park H; Choi Y; Jung CG; Park HS
    Mediators Inflamm; 2017; 2017():8160148. PubMed ID: 28852271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers for severe eosinophilic asthma.
    Yancey SW; Keene ON; Albers FC; Ortega H; Bates S; Bleecker ER; Pavord I
    J Allergy Clin Immunol; 2017 Dec; 140(6):1509-1518. PubMed ID: 29221581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilic Asthma, Phenotypes-Endotypes and Current Biomarkers of Choice.
    Porpodis K; Tsiouprou I; Apostolopoulos A; Ntontsi P; Fouka E; Papakosta D; Vliagoftis H; Domvri K
    J Pers Med; 2022 Jun; 12(7):. PubMed ID: 35887589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin-exacerbated respiratory disease: not always "adult-onset".
    Tuttle KL; Schneider TR; Henrickson SE; Morris D; Abonia JP; Spergel JM; Laidlaw TM
    J Allergy Clin Immunol Pract; 2016; 4(4):756-8. PubMed ID: 27393784
    [No Abstract]   [Full Text] [Related]  

  • 12. Eosinophilic Airway Diseases: From Pathophysiological Mechanisms to Clinical Practice.
    Mormile M; Mormile I; Fuschillo S; Rossi FW; Lamagna L; Ambrosino P; de Paulis A; Maniscalco M
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Biologics in Severe Asthma.
    Pavord ID; Hilvering B; Shrimanker R
    Immunol Allergy Clin North Am; 2016 Aug; 36(3):609-23. PubMed ID: 27401629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin or Nonsteroidal Anti-inflammatory Drug-Exacerbated Chronic Rhinosinusitis.
    Ledford DK; Lockey RF
    J Allergy Clin Immunol Pract; 2016; 4(4):590-8. PubMed ID: 27393773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Rhinosinusitis and Aspirin-Exacerbated Respiratory Disease.
    Dunn NM; Katial RK
    Immunol Allergy Clin North Am; 2016 Aug; 36(3):503-14. PubMed ID: 27401622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and pathologic perspectives on aspirin sensitivity and asthma.
    Stevenson DD; Szczeklik A
    J Allergy Clin Immunol; 2006 Oct; 118(4):773-86; quiz 787-8. PubMed ID: 17030227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics of Aspirin-Exacerbated Respiratory Disease.
    Stevenson DD; White AA
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):643-655. PubMed ID: 27712760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic mechanisms in asthma.
    Boonpiyathad T; Sözener ZC; Satitsuksanoa P; Akdis CA
    Semin Immunol; 2019 Dec; 46():101333. PubMed ID: 31703832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe Asthma and Biologics: Managing Complex Patients.
    Matucci A; Micheletto C; Vultaggio A
    J Investig Allergol Clin Immunol; 2023 Jun; 33(3):168-178. PubMed ID: 36059229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies.
    Chung KF
    J Intern Med; 2016 Feb; 279(2):192-204. PubMed ID: 26076339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.